Studies on the autonomic nervous system in borderline hypertension J. W. HenquetM. van BaakK. H. Rahn Originals Pages: 285 - 288
Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: A double-blind multicentre controlled study A. LechiS. PomariG. Baretta Originals Pages: 289 - 293
Pharmacokinetics and bioavailability of indapamide — A new antihypertensive drug P. E. GrebowJ. A. TreitmanE. S. Neiss Originals Pages: 295 - 299
Monoamine oxidase inhibition by tranylcypromine: Assessment in human volunteers P. R. BieckK. -H. Antonin Originals Pages: 301 - 308
Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol B. BrantmarkE. Wåhlin-BollA. Melander Originals Pages: 309 - 314
Pharmacokinetics of furosemide in patients with hepatic cirrhosis G. GonzálezA. ArancibiaC. Antezana Originals Pages: 315 - 320
The effect of sulphinpyrazone on oxidative drug metabolism in man: Inhibition of tolbutamide elimination J. O. MinersT. FoenanderD. J. Birkett Originals Pages: 321 - 326
Interaction of sulphinpyrazone with warfarin J. O. MinersT. FoenanderD. J. Birkett Originals Pages: 327 - 331
The effect of chlormethiazole on plasma adrenocorticotrophic hormone concentrations in chronic alcoholics Sisir K. Majumdar Originals Pages: 333 - 335
Effect of urinary pH on the disposition of methadone in man M. -I. NilssonE. WiderlövE. Änggård Originals Pages: 337 - 342
Pharmacokinetics of methadone during maintenance treatment: Adaptive changes during the induction phase M. -I. NilssonE. ÄnggårdL.-M. Gunne Originals Pages: 343 - 349
Drug distribution in whole blood of mothers and their newborn infants L. HerngrenM. EhrneboL. O. Boréus Originals Pages: 351 - 358
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults S. M. HuangN. K. AthanikarW. L. Chiou Originals Pages: 359 - 365
Plasma protein binding of perazine and amitriptyline in psychiatric patients M. BrinkschulteH. J. GaertnerU. Breyer-Pfaff Originals Pages: 367 - 373
Changes in nalorphine-induced hyperprolactinaemia after bromocriptine or sulpiride administration T. BarrecaG. MagnaniE. Rolandi Short Communication Pages: 375 - 376
Tolerability of high doses of (−)-moprolol in healthy volunteers M. O. TriulziG. BaliceP. Ghirardi Letter To The Editor Pages: 377 - 378